October 12, 2020
Article
Experts provide their perspectives on the evolving treatment landscape for patients with follicular lymphoma.
October 09, 2020
Article
Although the majority of patients with follicular lymphoma have a life expectancy similar to that of the general population, predicting which patients will relapse and finding therapies that provide durable responses in the relapsed or refractory setting remains an ongoing challenge.
September 14, 2020
Video
Kami J. Maddocks, MD, discusses the role of tazemetostat in patients with EZH2-mutant follicular lymphoma.
August 22, 2020
Video
Lori A. Leslie, MD, discusses a phase 1b study with tazemetostat plus lenalidomide and rituximab in patients with follicular lymphoma.
August 22, 2020
Video
Alan P. Z. Skarbnik, MD, discusses the watch-and-wait approach in patients with follicular lymphoma.
August 22, 2020
Video
John M. Burke, MD, discusses the role of tazemetostat in EZH2-mutated follicular lymphoma.
August 05, 2020
Video
Kami J. Maddocks, MD, discusses treatment considerations for treatment selection in follicular lymphoma.